Atom Bioworks is a biotechnology startup founded in 2020 with a focus on DNA nanostructures. This United States-based company has recently received a noteworthy $998.51K grant investment on July 20, 2022 from the National Science Foundation.
Atom Bioworks sets itself apart with its slogan "Program DNA for Life," reflecting its commitment to leveraging biotechnology to enhance healthcare and potentially revolutionize various industries. As the company continues to pave the way in healthcare innovation, its unique approach to DNA manipulation positions it as a notable player in the biotech landscape.
The recent investment from the National Science Foundation not only validates Atom Bioworks' potential but also signifies external recognition and support for its groundbreaking work. This injection of capital will undoubtedly fuel the company's growth and R&D efforts, further solidifying its position as a key player in the biotechnology and healthcare sectors. With its impressive achievements and significant support, Atom Bioworks represents an exciting prospect for potential venture capital investment and collaborative opportunities.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | $998.51K | 1 | 20 Jul 2022 | |
Non Equity Assistance | Unknown | 1 | 06 Jul 2022 | |
Seed Round | $3.00M | 2 | 21 May 2021 | |
Grant | $72.05K | 1 | One North Carolina Small Business Program | 02 Feb 2021 |
Seed Round | $125.00K | 1 | 03 Jan 2021 |